Lactobacillus reuteri NCIMB 30242 and Reduced Inflammatory Markers

• Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial

  • 2012-09-19
  • RCT · n = 127
  • European Journal of Clinical Nutrition 66(11)
  • • M. L. Jones
    • C. Martoni
    • S. Prakash

  • PubMed: 22990854
  • DOI: 10.1038/ejcn.2012.126

  19 Insights on

  • Reduced Inflammatory Markers

  • High evidence
  • Highly Cited
  • Rigorous Journal

  High-sensitivity C-reactive protein and fibrinogen were reduced by 1.05 mg/l (P = 0.005) and 14.25% (P = 0.004) relative to placebo, respectively.

  Effect

  Beneficial

  Effect size

  Small

  Significant

  Yes